Concepedia

Amparo Benedicto

AB

Statistics

Publications

16

Citations

1.3K

H-Index

13

Active since

2009

Affiliations

Hospital Universitario de La Princesa(Current)

Universidad Autónoma de Madrid

Instituto Cardiovascular de Rosario

University of Alabama at Birmingham

Hôpital Bichat-Claude-Bernard

Amparo Benedicto is an author at Hospital Universitario de La Princesa specializing in medicine, cardiology, and coronary artery disease.

Publications per year

2009–2022

16

Publications

16

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

, , +15

A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents

Fernándo Alfonso, Marı́a José Pérez-Vizcayno, Alberto Cárdenas et al. · Journal of the American College of Cardiology · 2015 · 308 citations · Full text

, , +14

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

, , +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

, , +17

3-Year Clinical Follow-Up of the RIBS IV Clinical Trial

Fernándo Alfonso, Marı́a José Pérez-Vizcayno, Javier Cuesta et al. · JACC: Cardiovascular Interventions · 2018 · 113 citations · Full text

, , +4

1–5 of 16